Ribonaut Therapeutics, Inc. — Form D
Ribonaut Therapeutics, Inc. of JUPITER, FL, a company, filed a Form D exempt-offering notice with the SEC on 2023-01-04. The offering totals $26.0M, of which $6.9M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-01-04
- Form: D
- Accession: 0001956680-23-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $26.0M
- Amount sold: $6.9M
- Remaining: $19.1M
- Investors: 6
- Date of first sale: 2022-11-14
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-469691
Issuer
- Name: Ribonaut Therapeutics, Inc.
- CIK: 0001956680
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 492 PEACOCK LN N, JUPITER, FL, 33458
- Phone: 716-380-7737
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Matthew Disney | Director | JUPITER, FL |
| LUSONG LUO | Director | PITTSBURGH, PA |
| Steven Tregay | Director | JUPITER, FL |
| Zachary Collins | Executive Officer | Holland, MI |
| Matthew Disney | Executive Officer | JUPITER, FL |
| Jessica Childs-Disney | Promoter | JUPITER, FL |
More